New anticoagulants--the path from discovery to clinical practice.
Publication
, Journal Article
Lohrmann, J; Becker, RC
Published in: N Engl J Med
June 26, 2008
Duke Scholars
Published In
N Engl J Med
DOI
EISSN
1533-4406
Publication Date
June 26, 2008
Volume
358
Issue
26
Start / End Page
2827 / 2829
Location
United States
Related Subject Headings
- Venous Thrombosis
- Venous Thromboembolism
- Thiophenes
- Rivaroxaban
- Morpholines
- Humans
- General & Internal Medicine
- Factor Xa Inhibitors
- Enoxaparin
- Anticoagulants
Citation
APA
Chicago
ICMJE
MLA
NLM
Lohrmann, J., & Becker, R. C. (2008). New anticoagulants--the path from discovery to clinical practice. N Engl J Med, 358(26), 2827–2829. https://doi.org/10.1056/NEJMe0804291
Lohrmann, Jens, and Richard C. Becker. “New anticoagulants--the path from discovery to clinical practice.” N Engl J Med 358, no. 26 (June 26, 2008): 2827–29. https://doi.org/10.1056/NEJMe0804291.
Lohrmann J, Becker RC. New anticoagulants--the path from discovery to clinical practice. N Engl J Med. 2008 Jun 26;358(26):2827–9.
Lohrmann, Jens, and Richard C. Becker. “New anticoagulants--the path from discovery to clinical practice.” N Engl J Med, vol. 358, no. 26, June 2008, pp. 2827–29. Pubmed, doi:10.1056/NEJMe0804291.
Lohrmann J, Becker RC. New anticoagulants--the path from discovery to clinical practice. N Engl J Med. 2008 Jun 26;358(26):2827–2829.
Published In
N Engl J Med
DOI
EISSN
1533-4406
Publication Date
June 26, 2008
Volume
358
Issue
26
Start / End Page
2827 / 2829
Location
United States
Related Subject Headings
- Venous Thrombosis
- Venous Thromboembolism
- Thiophenes
- Rivaroxaban
- Morpholines
- Humans
- General & Internal Medicine
- Factor Xa Inhibitors
- Enoxaparin
- Anticoagulants